| Delivering the promise of miRNA cancer therapeutics DM Pereira, PM Rodrigues, PM Borralho, CMP Rodrigues Drug discovery today 18 (5-6), 282-289, 2013 | 344 | 2013 |
| Efficient recovery of proteins from multiple source samples after trizol® or trizol®LS RNA extraction and long-term storage AES Simões, DM Pereira, JD Amaral, AF Nunes, SE Gomes, ... BMC genomics 14, 1-15, 2013 | 118 | 2013 |
| Cyclopentadienyl–ruthenium (II) and iron (II) organometallic compounds with carbohydrate derivative ligands as good colorectal anticancer agents PR Florindo, DM Pereira, PM Borralho, CMP Rodrigues, MFM Piedade, ... Journal of Medicinal Chemistry 58 (10), 4339-4347, 2015 | 91 | 2015 |
| c-Jun N-terminal kinase 1/c-Jun activation of the p53/microRNA 34a/sirtuin 1 pathway contributes to apoptosis induced by deoxycholic acid in rat liver DMS Ferreira, MB Afonso, PM Rodrigues, AL Simão, DM Pereira, ... Molecular and cellular biology 34 (6), 1100-1120, 2014 | 87 | 2014 |
| MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism DM Pereira, AES Simões, SE Gomes, RE Castro, T Carvalho, ... Oncotarget 7 (23), 34322, 2016 | 63 | 2016 |
| Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation AES Simões, DM Pereira, SE Gomes, H Brito, T Carvalho, A French, ... Cell death & disease 6 (4), e1718-e1718, 2015 | 62 | 2015 |
| miR-143 or miR-145 overexpression increases cetuximab-mediated antibody-dependent cellular cytotoxicity in human colon cancer cells SE Gomes, AES Simões, DM Pereira, RE Castro, CMP Rodrigues, ... Oncotarget 7 (8), 9368, 2016 | 58 | 2016 |
| Convergence of miR-143 overexpression, oxidative stress and cell death in HCT116 human colon cancer cells SE Gomes, DM Pereira, C Roma-Rodrigues, AR Fernandes, PM Borralho, ... PloS one 13 (1), e0191607, 2018 | 52 | 2018 |
| MEK5/ERK5 activation regulates colon cancer stem-like cell properties DM Pereira, SE Gomes, PM Borralho, CMP Rodrigues Cell death discovery 5 (1), 68, 2019 | 43 | 2019 |
| The histone deacetylase inhibitor panobinostat is a potent antitumor agent in canine diffuse large B-cell lymphoma JNR Dias, SI Aguiar, DM Pereira, AS André, L Gano, JDG Correia, ... Oncotarget 9 (47), 28586, 2018 | 35 | 2018 |
| Targeted Avenues for Cancer Treatment: The MEK5–ERK5 Signaling Pathway DM Pereira, CMP Rodrigues Trends in molecular medicine 26 (4), 394-407, 2020 | 34 | 2020 |
| New [(η 5-C 5 H 5) Ru (N–N)(PPh 3)][PF 6] compounds: colon anticancer activity and GLUT-mediated cellular uptake of carbohydrate-appended complexes PR Florindo, DM Pereira, PM Borralho, PJ Costa, MFM Piedade, ... Dalton Transactions 45 (30), 11926-11930, 2016 | 28 | 2016 |
| Organoruthenium (II) nucleoside conjugates as colon cytotoxic agents PR Florindo, DM Pereira, PM Borralho, MFM Piedade, MC Oliveira, ... New Journal of Chemistry 43 (3), 1195-1201, 2019 | 6 | 2019 |
| miRNAs as modulators of EGFR therapy in colorectal cancer DM Pereira, CMP Rodrigues Targeted Therapy of Colorectal Cancer Subtypes, 133-147, 2018 | 4 | 2018 |
| A formação do pedagogo para o uso das tecnologias: uma análise de diferentes currículos DMC PEREIRA, NMB Pasinato XI Congreso Internacional Galego-Portugués de Psicopedagoxía, 2011 | 1 | 2011 |
| Exploring mek5-erk5 signaling in colorectal cancer: A therapeutic target for chemosensitization DM Pereira | | 2019 |
| This journal is© The Royal Society of Chemistry 2016 PR Florindo, DM Pereira, PM Borralho, PJ Costa, MFM Piedade, ... | | |
Pedro BorralhoResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, University of Lisbon在 ff.ulisboa.pt 的电子邮件经过验证
